Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Neurology

Daily Management and Protecting Your Brain

At a Glance

The most important part of managing CADASIL is strict blood pressure control (usually under 130/80) to prevent brain bleeds and strokes. Patients must also avoid smoking and certain medications that constrict blood vessels, like triptans for migraines and estrogen-based birth control.

While there is currently no cure or “disease-modifying” treatment that can stop the genetic cause of CADASIL, how you manage your health every day has a massive impact on your quality of life and the speed of the disease’s progression [1][2]. Management is focused on one primary goal: brain protection.

The Gold Standard: Blood Pressure Control

Strict blood pressure control is the single most important tool in your arsenal [3]. Because the walls of your brain’s blood vessels are weakened and stiffened by the NOTCH3 mutation, they are much less “forgiving” of high pressure than healthy vessels [4][5].

  • Why it matters: Uncontrolled high blood pressure (hypertension) significantly increases the risk of intracerebral hemorrhage (a brain bleed) [6][7]. It also accelerates the development of white matter damage and “silent” strokes [8].
  • The Target: While your doctor will set a personalized goal, most experts recommend keeping blood pressure below 130/80 mmHg [3]. Consistency is key—even temporary spikes in pressure can put a strain on fragile vessels.

Medication Safety: What to Avoid

Because CADASIL makes your brain’s blood vessels prone to narrowing and less able to adapt to changes in blood flow, certain common medications can be dangerous [5].

  • Migraine Medications (Triptans and Ergots): These drugs work by constricting (narrowing) blood vessels to stop headache pain [9]. In a CADASIL patient, this constriction can dangerously reduce blood flow to an already vulnerable brain [10][11].
    • Safer Alternatives: Newer migraine treatments like gepants (e.g., rimegepant) or lasmiditan may be safer options because they do not constrict blood vessels in the same way [12][13].
  • Estrogen and Oral Contraceptives: Women with CADASIL often experience migraines with aura early in life. Taking estrogen-containing birth control pills or hormone replacement therapy (HRT) heavily compounds your risk of having an ischemic stroke [14]. Always discuss non-estrogen or localized hormone options with your doctor.
  • Invasive Procedures: Certain procedures like cerebral angiography (where a catheter is threaded into the brain’s vessels) carry a higher risk of triggering a stroke in CADASIL patients and should only be performed when absolutely necessary [5].

The Antiplatelet and Statin Dilemmas

Doctors often prescribe “blood thinners” (antiplatelets like aspirin or clopidogrel) and cholesterol-lowering drugs (statins) to prevent strokes in the general population. In CADASIL, these choices are more nuanced [15][3].

  • The Antiplatelet Dilemma: CADASIL patients face a risk of ischemic strokes (blockages), which antiplatelets help prevent. However, they also face a risk of intracerebral hemorrhage (bleeding), which antiplatelets can make worse [16][7]. Doctors will usually check your MRI for “microbleeds” before making this decision [3].
  • The Statin Dilemma: While statins lower cholesterol, research shows that high-dose statins can occasionally increase the risk of bleeding in the brain, especially in small vessel diseases [15]. Your doctor will weigh your overall cholesterol levels against your specific bleeding risk.

Essential Lifestyle Actions

  1. Quit Smoking Immediately: Smoking is an independent and powerful predictor of early stroke and dementia in CADASIL patients [8]. It is the most preventable way to slow the disease.
  2. Monitor at Home: Don’t rely solely on the blood pressure readings at your doctor’s office. Keep a daily log at home to ensure you are consistently within your target range [3].
  3. Exercise Safely: Staying active is great for brain health, but you must avoid activities that cause sudden, extreme spikes in blood pressure (like heavy powerlifting, straining, or holding your breath) because your brain’s blood vessels struggle to compensate for extreme pressure changes [5][17]. Focus instead on steady, moderate aerobic exercise like brisk walking, light jogging, or yoga.

Common questions in this guide

What is the target blood pressure for someone with CADASIL?
While individual goals vary, most experts recommend keeping blood pressure consistently below 130/80 mmHg. Strict blood pressure control is crucial for preventing both ischemic strokes and brain bleeds in CADASIL patients.
Can I take triptans for CADASIL migraines?
No, triptans and ergots are generally unsafe for CADASIL patients because they constrict blood vessels. Your doctor may recommend safer alternatives like gepants or lasmiditan that do not dangerously reduce blood flow to the brain.
Is it safe to use oral contraceptives if I have CADASIL?
Women with CADASIL should avoid estrogen-containing birth control pills and hormone replacement therapy. Estrogen significantly increases the risk of suffering an ischemic stroke, so it is important to discuss non-estrogen options with your doctor.
Should CADASIL patients take aspirin to prevent strokes?
The use of aspirin or other antiplatelets in CADASIL is complex. While they help prevent stroke-causing blockages, they can also increase the risk of bleeding in the brain. Your doctor will likely check your MRI for microbleeds before making a recommendation.
What type of exercise is safe for CADASIL?
Moderate aerobic exercises like brisk walking, light jogging, or yoga are excellent for brain health. You should avoid heavy powerlifting, straining, or holding your breath, as these can cause extreme spikes in blood pressure that strain fragile blood vessels.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my specific target blood pressure, and how often should I be monitoring it at home?
  2. 2.Based on the number of microbleeds on my MRI, are antiplatelets like aspirin or clopidogrel safe for me?
  3. 3.What migraine medications can I safely use instead of triptans or ergots?
  4. 4.Are there any elective procedures or diagnostic tests, like an angiography, that I should avoid?
  5. 5.Can you help me evaluate the stroke risks associated with my current birth control or hormone replacement therapy?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Pathogenesis and therapeutic advances of cerebral autosomal- dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

    Zhang Y, Wu ZY

    Yi chuan = Hereditas 2023; (45(7)):568-579 doi:10.16288/j.yczz.23-023.

    PMID: 37503581
  2. 2

    Management of Inherited CNS Small Vessel Diseases: The CADASIL Example: A Scientific Statement From the American Heart Association.

    Meschia JF, Worrall BB, Elahi FM, et al.

    Stroke 2023; (54(10)):e452-e464 doi:10.1161/STR.0000000000000444.

    PMID: 37602377
  3. 3

    Intracerebral hemorrhage in CADASIL.

    Hsu SL, Liao YC, Chung CP, et al.

    Journal of the Chinese Medical Association : JCMA 2025; (88(3)):189-195 doi:10.1097/JCMA.0000000000001206.

    PMID: 39806999
  4. 4

    Cadasil syndrome: A case report with a literature review.

    Lahkim M, Laamrani FZ, Andour H, et al.

    Radiology case reports 2021; (16(11)):3540-3543 doi:10.1016/j.radcr.2021.08.023.

    PMID: 34584593
  5. 5

    Acute bilateral multiple subcortical infarcts as manifestation in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

    Huang H, Xie W, Hu F, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2023; (44(12)):4391-4399 doi:10.1007/s10072-023-06949-9.

    PMID: 37458844
  6. 6

    Intracerebral Hemorrhage in Patients With CADASIL: Additive Impact of the NOTCH3 R544C Variant and Hypertension?

    Chen CH, Cheng YW, Zhang R, et al.

    Stroke 2025; (56(8)):2159-2166 doi:10.1161/STROKEAHA.124.050484.

    PMID: 40270244
  7. 7

    R558C NOTCH3 Mutation in a CADASIL Patient with Intracerebral Hemorrhage: A Case Report with Literature Review.

    Hu L, Liu G, Fan Y

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2022; (31(7)):106541 doi:10.1016/j.jstrokecerebrovasdis.2022.106541.

    PMID: 35523050
  8. 8

    Predictors of Clinical Worsening in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Prospective Cohort Study.

    Chabriat H, Hervé D, Duering M, et al.

    Stroke 2016; (47(1)):4-11 doi:10.1161/STROKEAHA.115.010696.

    PMID: 26578659
  9. 9

    Headache: Treatment update.

    Ogunlaja OI, Goadsby PJ

    eNeurologicalSci 2022; (29()):100420 doi:10.1016/j.ensci.2022.100420.

    PMID: 36636337
  10. 10

    Cardiovascular Events, Conditions, and Procedures Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.

    Buse DC, Reed ML, Fanning KM, et al.

    Headache 2017; (57(1)):31-44 doi:10.1111/head.12962.

    PMID: 27861837
  11. 11

    Lasmiditan: Acute Migraine Treatment Without Vasoconstriction. A Review.

    Beauchene JK, Levien TL

    The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians 2021; (37(5)):244-253 doi:10.1177/87551225211024630.

    PMID: 34752575
  12. 12

    Rimegepant for acute treatment of migraine in triptan-unsuitable adults: A randomized, double-blind, placebo-controlled phase 4 trial.

    Ashina M, McAllister P, Gaul C, et al.

    Cephalalgia : an international journal of headache 2025; (45(11)):3331024251395298 doi:10.1177/03331024251395298.

    PMID: 41255093
  13. 13

    Lasmiditan: an additional therapeutic option for the acute treatment of migraine.

    Martinelli D, Bitetto V, Tassorelli C

    Expert review of neurotherapeutics 2021; (21(5)):491-502 doi:10.1080/14737175.2021.1912599.

    PMID: 33866907
  14. 14

    Ataxia Associated with CADASIL: a Pathology-Confirmed Case Report and Literature Review.

    Park DG, Min JH, Sohn SH, et al.

    Cerebellum (London, England) 2020; (19(6)):907-910 doi:10.1007/s12311-020-01173-z.

    PMID: 32734377
  15. 15

    Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) in a 32-Year-Old Male Presenting With a Transient Ischemic Attack (TIA).

    Karim R, Malik M, Cheema H, et al.

    Cureus 2024; (16(10)):e70970 doi:10.7759/cureus.70970.

    PMID: 39507177
  16. 16

    Intracerebral Hemorrhage in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Prevalence, Clinical and Neuroimaging Features and Risk Factors.

    Liao YC, Hu YC, Chung CP, et al.

    Stroke 2021; (52(3)):985-993 doi:10.1161/STROKEAHA.120.030664.

    PMID: 33535780
  17. 17

    Stem Cell Factor in Combination With Granulocyte Colony-Stimulating Factor Protects the Brain From Capillary Thrombosis-Induced Ischemic Neuron Loss in a Mouse Model of CADASIL.

    Ping S, Qiu X, Gonzalez-Toledo ME, et al.

    Frontiers in cell and developmental biology 2020; (8()):627733 doi:10.3389/fcell.2020.627733.

    PMID: 33511138

This page provides educational information about managing CADASIL and protecting brain health. Always consult your neurologist before starting, stopping, or changing any medications or treatments.

Get notified when new evidence is published on Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.